These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 23020540

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The relation of ambulatory blood pressure and pulse rate to retinopathy in type 1 diabetes mellitus: the renin-angiotensin system study.
    Klein R, Moss SE, Sinaiko AR, Zinman B, Gardiner R, Suissa S, Donnelly SM, Kramer MS, Goodyer P, Strand T, Mauer M.
    Ophthalmology; 2006 Dec; 113(12):2231-6. PubMed ID: 16996597
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Antihypertensive strategy based on angiotensin II receptor blockers: a new gateway to reduce risk in hypertension.
    Tocci G, Sciarretta S, Facciolo C, Volpe M.
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):767-76. PubMed ID: 17605654
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Pharmacological approach to diabetic retinopathy.
    De La Cruz JP, González-Correa JA, Guerrero A, de la Cuesta FS.
    Diabetes Metab Res Rev; 2004 Jul; 20(2):91-113. PubMed ID: 15037985
    [Abstract] [Full Text] [Related]

  • 34. Dyslipidemia and hypertension in patients with type 2 diabetes and retinopathy.
    Popescu T, Moţa M.
    Rom J Intern Med; 2009 Jul; 47(3):235-41. PubMed ID: 20446438
    [Abstract] [Full Text] [Related]

  • 35. Medical treatment of retinopathy of type-2 diabetes.
    Cunha-Vaz JG.
    Ophthalmologica; 2004 Jul; 218(5):291-6. PubMed ID: 15334008
    [Abstract] [Full Text] [Related]

  • 36. Angiotensin II type 1 receptor blockade: high hopes sent back to reality?
    Grothusen A, Divchev D, Luchtefeld M, Schieffer B.
    Minerva Cardioangiol; 2009 Dec; 57(6):773-85. PubMed ID: 19942847
    [Abstract] [Full Text] [Related]

  • 37. Prevention and treatment of diabetic retinopathy: evidence from large, randomized trials. The emerging role of fenofibrate.
    Simó R, Hernández C.
    Rev Recent Clin Trials; 2012 Feb; 7(1):71-80. PubMed ID: 21864248
    [Abstract] [Full Text] [Related]

  • 38. Effects on protein kinase C-beta inhibition on glomerular vascular endothelial growth factor expression and endothelial cells in advanced experimental diabetic nephropathy.
    Kelly DJ, Buck D, Cox AJ, Zhang Y, Gilbert RE.
    Am J Physiol Renal Physiol; 2007 Aug; 293(2):F565-74. PubMed ID: 17522264
    [Abstract] [Full Text] [Related]

  • 39. Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade.
    Lip PL, Chatterjee S, Caine GJ, Hope-Ross M, Gibson J, Blann AD, Lip GY.
    Br J Ophthalmol; 2004 Dec; 88(12):1543-6. PubMed ID: 15548809
    [Abstract] [Full Text] [Related]

  • 40. The renin-angiotensin-aldosterone system and the eye in diabetes.
    Strain WD, Chaturvedi N.
    J Renin Angiotensin Aldosterone Syst; 2002 Dec; 3(4):243-6. PubMed ID: 12584667
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.